Stock Options (Details 1) - USD ($) |
3 Months Ended | 12 Months Ended |
|---|---|---|
Nov. 30, 2021 |
Aug. 31, 2021 |
|
| Stock Options | ||
| Balance, Outstanding | 206,170 | 171,604 |
| Expired/Cancelled | (3,334) | 50,344 |
| Granted | 81,800 | 84,900 |
| Balance Exercisable | 270,803 | |
| Balance, Outstanding | 284,636 | 206,170 |
| Weighted average exercise price, Balance, Outstanding | $ 8.90 | $ 11.17 |
| Weighted average exercise price, Expired/Cancelled | 9.60 | 10.76 |
| Weighted average exercise price, Granted | 6.23 | 5.41 |
| Weighted average exercise price, Balance, Outstanding | 8.12 | $ 8.90 |
| Weighted average exercise price, Balance, Exercisable | $ 8.22 | |
| Weighted Average Remaining Contractual Term, Outstanding (Years) | 3 years 10 months 9 days | |
| Weighted Average Remaining Contractual Term, Exercisable (Years) | 3 years 10 months 2 days | |
| Aggregate Intrinsic Value, Outstanding | $ 4,820 | |
| Aggregate Intrinsic Value, Exercisable | $ 2,740 |
| X | ||||||||||
- Definition Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. No definition available.
|
| X | ||||||||||
- Definition Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired. No definition available.
|
| X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. No definition available.
|
| X | ||||||||||
- Definition Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|